MedPath

Capnia, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia

Phase 2
Completed
Conditions
Trigeminal Neuralgia
Interventions
First Posted Date
2015-06-16
Last Posted Date
2017-11-17
Lead Sponsor
Capnia, Inc.
Target Recruit Count
30
Registration Number
NCT02473016
Locations
🇺🇸

Medical University of South Carolina (MUSC), Charleston, South Carolina, United States

🇺🇸

University of Virginia, Charlottesville, Virginia, United States

🇺🇸

University of California, Los Angeles (UCLA), Los Angeles, California, United States

and more 3 locations

The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine

Phase 2
Terminated
Conditions
Migraine
Interventions
First Posted Date
2010-12-06
Last Posted Date
2013-10-31
Lead Sponsor
Capnia, Inc.
Target Recruit Count
35
Registration Number
NCT01253915
Locations
🇺🇸

Walter Reed National Military Medical Center - Dept of Neurology, Bethesda, Maryland, United States

🇺🇸

Naval Medical Center San Diego - Dept of Neurology, San Diego, California, United States

🇺🇸

Naval Medical Center Portsmouth - Dept of Neurology, Portsmouth, Virginia, United States

The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis

Phase 2
Completed
Conditions
Seasonal Allergic Rhinitis
Interventions
Drug: Nasal CO2
Drug: Inactive Placebo Gas
First Posted Date
2009-06-10
Last Posted Date
2012-08-15
Lead Sponsor
Capnia, Inc.
Target Recruit Count
32
Registration Number
NCT00917020
Locations
🇺🇸

Capnia Investigative Site, St. Louis, Missouri, United States

The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis

Phase 2
Completed
Conditions
Seasonal Allergic Rhinitis
Interventions
Drug: Nasal CO2
Drug: Inactive Placebo Gas
First Posted Date
2009-06-10
Last Posted Date
2012-08-15
Lead Sponsor
Capnia, Inc.
Target Recruit Count
33
Registration Number
NCT00917111
Locations
🇺🇸

Capnia Investigative Site, Omaha, Nebraska, United States

The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines

Phase 2
Completed
Conditions
Migraine
Interventions
Drug: Inactive Placebo
Drug: Nasal CO2
First Posted Date
2008-06-05
Last Posted Date
2012-08-15
Lead Sponsor
Capnia, Inc.
Target Recruit Count
292
Registration Number
NCT00690716
Locations
🇺🇸

Capnia Investigative Site, Seattle, Washington, United States

The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis

Phase 2
Completed
Conditions
Seasonal Allergic Rhinitis
Interventions
Drug: Nasal CO2
Drug: Placebo
First Posted Date
2008-06-03
Last Posted Date
2010-08-20
Lead Sponsor
Capnia, Inc.
Target Recruit Count
453
Registration Number
NCT00688441

The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis

Phase 2
Completed
Conditions
Perennial Allergic Rhinitis
Interventions
First Posted Date
2008-03-19
Last Posted Date
2010-08-19
Lead Sponsor
Capnia, Inc.
Target Recruit Count
20
Registration Number
NCT00638755
Locations
🇺🇸

Capnia Investigative Site, Omaha, Nebraska, United States

Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain

Phase 2
Completed
Conditions
Headaches
Temporomandibular Disorders
Pain
Interventions
First Posted Date
2007-06-08
Last Posted Date
2010-08-20
Lead Sponsor
Capnia, Inc.
Target Recruit Count
100
Registration Number
NCT00484029
Locations
🇺🇸

University of Washington, Department of Oral Medicine, Box 356370, Health Sciences Building, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath